Exagen (XGN) said Thursday that it priced its previously announced underwritten public offering of 3.35 million common shares at $5.25 apiece for expected gross proceeds of about $17.6 million.
The company said it granted the underwriters a 30-day option to purchase up to 502,500 additional shares at the same offering price.
Exagen expects to close the offering on Friday.
Shares of Exagen were down 8.4% in recent Thursday trading.
Price: 6.26, Change: -0.57, Percent Change: -8.35
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。